Top officials from the two groups believe it’s unlikely the FDA can provide assurances of such technology’s safety in imaging care, absent further testing, surveillance and other methods of oversight.
The money comes by way of the European Innovation Council Accelerator and balloons Quantib's fundraising total to almost $13.5 million (USD), officials said Tuesday.
Stanford University experts call their new neural network “LungNet” and say the system has delivered consistent, fast and accurate interpretation of computed tomography scans.
Deep01 said the lion’s share of the contribution comes by way of electronics manufacturer Asus, with other Taiwan-based firms such as BE Capital also contributing.
London investment firm MMC Ventures is pitching in the largest share of capital, with additional contributions from Bayer, Seedcamp and InHealth Ventures, Agamon announced Monday.
The National Cancer Institute model only accounts for colon and breast cancer screenings and represents a roughly 1% increase over pre-COVID-19 estimates.
Vara recently announced the new capital contribution, with the venture investment arm of the Ontario Municipal Employees Retirement System pitching in the largest share.
In magnetic resonance alone, the Chicago-based corporation estimated that U.S. providers have postponed upward of 5 million scans since the pandemic started.
Australia-based 4DMedical said the software can also assist in assessing patients with asthma, chronic obstructive pulmonary disease, cystic fibrosis and lung cancer.
Johns Hopkins has scored a $195,000 grant from the National Science Foundation, with its scientists now beginning the first phase of the one-year research project.
That’s according to the results of a new investigation, led by University of Cambridge experts and published
in the Proceedings of the National Academy of Sciences.
